Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CABA Cabaletta Bio

已收盘 12-17 16:00:00 EST

2.33

-0.06

-2.51%

盘后2.30

-0.03-1.29%

19:13 EST

最高2.44	最低2.32	成交量161.20万
今开2.39	昨收2.39	日振幅5.02%
总市值2.24亿	流通市值1.44亿	总股本9,627万
成交额380.66万	换手率2.61%	流通股本6,164万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CABA","market":"US","secType":"STK","nameCN":"Cabaletta Bio","latestPrice":2.33,"timestamp":1766005200000,"preClose":2.39,"halted":0,"volume":1611977,"hourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.33,"latestTime":"19:13 EST","volume":18627,"amount":43579.0795,"timestamp":1766016802035},"delay":0,"floatShares":61644722,"shares":96265204,"eps":-2.407485,"marketStatus":"已收盘","change":-0.06,"latestTime":"12-17 16:00:00 EST","open":2.39,"high":2.44,"low":2.32,"amount":3806641.1293072,"amplitude":0.050209,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.407485,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":5,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":2.39,"preHourTrading":{"tag":"盘前","latestPrice":2.4107,"preClose":2.39,"latestTime":"09:02 EST","volume":5140,"amount":12485.675772,"timestamp":1765980159522},"postHourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.33,"latestTime":"19:13 EST","volume":18627,"amount":43579.0795,"timestamp":1766016802035},"volumeRatio":1.100555,"impliedVol":0.8778,"impliedVolPercentile":0.396},"requestUrl":"/m/hq/s/CABA/wiki","defaultTab":"wiki","newsList":[{"id":"2586249714","title":"Cabaletta Bio, Inc.盘中异动 早盘急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586249714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586249714?lang=zh_cn&edition=full","pubTime":"2025-11-27 00:16","pubTimestamp":1764173778,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日00时16分，Cabaletta Bio, Inc.股票出现波动，股价快速上涨5.45%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511270016189781028a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511270016189781028a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2586166794","title":"Cabaletta Bio, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586166794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586166794?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:05","pubTimestamp":1763996751,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时05分，Cabaletta Bio, Inc.股票出现异动，股价快速上涨5.05%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124230551a4b761d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124230551a4b761d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2582188933","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582188933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582188933?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:59","pubTimestamp":1762873186,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日22时59分，Cabaletta Bio, Inc.股票出现异动，股价大幅拉升5.35%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111225946a6f247c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111225946a6f247c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2578620605","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.30%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578620605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578620605?lang=zh_cn&edition=full","pubTime":"2025-10-27 21:35","pubTimestamp":1761572155,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日21时35分，Cabaletta Bio, Inc.股票出现异动，股价快速拉升5.30%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027213555a6d0e7c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027213555a6d0e7c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"1109522248","title":"Cabaletta Bio：三名患者在输注后首月内B细胞显著减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1109522248","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109522248?lang=zh_cn&edition=full","pubTime":"2025-10-10 00:13","pubTimestamp":1760026395,"startTime":"0","endTime":"0","summary":"Cabaletta Bio表示，三名患者均在输注后首月内经历了B细胞的显著减少。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2572057379","title":"Cabaletta Bio, Inc.盘中异动 大幅拉升5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572057379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572057379?lang=zh_cn&edition=full","pubTime":"2025-10-03 00:20","pubTimestamp":1759422035,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日00时20分，Cabaletta Bio, Inc.股票出现波动，股价急速上涨5.19%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100300203594b8c735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100300203594b8c735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2563966006","title":"Cabaletta Bio, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563966006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563966006?lang=zh_cn&edition=full","pubTime":"2025-08-30 01:18","pubTimestamp":1756487921,"startTime":"0","endTime":"0","summary":"北京时间2025年08月30日01时18分，Cabaletta Bio, Inc.股票出现波动，股价急速下挫5.00%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830011842976a5c92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830011842976a5c92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2559494857","title":"Cabaletta Bio, Inc.8月14日成交额为210.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559494857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559494857?lang=zh_cn&edition=full","pubTime":"2025-08-15 09:34","pubTimestamp":1755221660,"startTime":"0","endTime":"0","summary":"美东时间2025年8月14日，Cabaletta Bio, Inc.成交额为210.71万美元，成交额较昨日减少76.90%，当日成交量为131.74万股。Cabaletta Bio, Inc.于2025年8月14日跌3.51%，报1.65美元，该股过去5个交易日涨13.79%，年初至今跌27.31%，过去60日跌14.06%。其专有技术利用嵌合自身抗体受体或 CAART 细胞，这些细胞旨在选择性结合并仅消除产生致病自身抗体或致病性 B 细胞的特定 B 细胞，同时保留正常 B 细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815093937a4899a68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815093937a4899a68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2558471575","title":"Cabaletta Bio, Inc.盘中异动 早盘急速跳水5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558471575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558471575?lang=zh_cn&edition=full","pubTime":"2025-08-08 23:22","pubTimestamp":1754666544,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日23时22分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808232225a47d8550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808232225a47d8550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2557308318","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308318?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:56","pubTimestamp":1754488616,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时56分，Cabaletta Bio, Inc.股票出现波动，股价大幅下跌5.15%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806215656973792bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806215656973792bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2557333677","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.21%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557333677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557333677?lang=zh_cn&edition=full","pubTime":"2025-08-05 00:30","pubTimestamp":1754325013,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日00时30分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.21%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080500301497334367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080500301497334367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2556843728","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556843728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556843728?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:24","pubTimestamp":1754076252,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时24分，Cabaletta Bio, Inc.股票出现异动，股价快速跳水5.21%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080203241294c993e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080203241294c993e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2555050445","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.01%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555050445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555050445?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:23","pubTimestamp":1753802614,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时23分，Cabaletta Bio, Inc.股票出现异动，股价急速跳水5.01%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292323349725affb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292323349725affb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2551126012","title":"Cabaletta Bio, Inc.盘中异动 早盘大幅拉升5.52%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126012?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:32","pubTimestamp":1752676350,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时32分，Cabaletta Bio, Inc.股票出现波动，股价大幅拉升5.52%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716223231a6adbb20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716223231a6adbb20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2551806311","title":"Cabaletta Bio, Inc.盘中异动 急速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551806311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551806311?lang=zh_cn&edition=full","pubTime":"2025-07-15 00:04","pubTimestamp":1752509059,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时04分，Cabaletta Bio, Inc.股票出现异动，股价急速下跌5.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500041997a5e015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500041997a5e015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2550865929","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.26%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550865929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550865929?lang=zh_cn&edition=full","pubTime":"2025-07-09 23:08","pubTimestamp":1752073714,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时08分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.26%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230834979fcbb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230834979fcbb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2549558721","title":"Cabaletta Bio, Inc.盘中异动 早盘快速下挫5.83%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558721?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:36","pubTimestamp":1751895366,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时36分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.83%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213606a69b1b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213606a69b1b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2548886859","title":"Cabaletta Bio, Inc.盘中异动 快速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886859?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:19","pubTimestamp":1751386769,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时19分，Cabaletta Bio, Inc.股票出现波动，股价大幅上涨5.22%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001929a728cbbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001929a728cbbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2546729648","title":"Cabaletta Bio, Inc.盘中异动 临近收盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729648?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:50","pubTimestamp":1751053817,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.29%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035017952e7978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035017952e7978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2546275648","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.08%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546275648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546275648?lang=zh_cn&edition=full","pubTime":"2025-06-27 03:35","pubTimestamp":1750966503,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日03时35分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.08%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627033503a4bfa7fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627033503a4bfa7fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cabalettabio.com","stockEarnings":[{"period":"1week","weight":-0.044},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.2448},{"period":"6month","weight":0.3815},{"period":"1year","weight":-0.1181},{"period":"ytd","weight":0.0529}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发工程化T细胞疗法，这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的，也许是治疗性的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.048317},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.157271},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.183657},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.082027},{"month":5,"riseRate":0.5,"avgChangeRate":0.078617},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.047367},{"month":7,"riseRate":0.5,"avgChangeRate":0.001813},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.019431},{"month":9,"riseRate":0.666667,"avgChangeRate":0.071635},{"month":10,"riseRate":0.666667,"avgChangeRate":0.33715},{"month":11,"riseRate":0.714286,"avgChangeRate":0.286048},{"month":12,"riseRate":0.428571,"avgChangeRate":0.026996}],"exchange":"NASDAQ","name":"Cabaletta Bio","nameEN":"Cabaletta Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cabaletta Bio,CABA,Cabaletta Bio股票,Cabaletta Bio股票老虎,Cabaletta Bio股票老虎国际,Cabaletta Bio行情,Cabaletta Bio股票行情,Cabaletta Bio股价,Cabaletta Bio股市,Cabaletta Bio股票价格,Cabaletta Bio股票交易,Cabaletta Bio股票购买,Cabaletta Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}